biomarkers
WMNF: Tampa plays role in study detecting early Alzheimer’s
Posted on October 2, 2025 • by Julia Ferrar Most biomarker tests, such as PET scans and spinal taps, are expensive or invasive and can pose risks for patients. That’s why a company in the Tampa Bay area is helping to research blood tests for biomarkers as a less expensive and more accessible alternative. Axiom […]
FOX 13 Unscripted: Alzheimer’s Awareness
FOX 13’s Allie Corey and her guest discuss Alzheimer’s and the latest research in the disease. Watch the interview with Dr. Steen of Axiom Brain Health here: https://www.fox13news.com/video/1715786
PSI TV: Prevent Cognitive Decline with These Proven Lifestyle Changes
Prevent cognitive decline with these proven lifestyle changes! Join us on PSI TV as Dr. Susan Steen, MD, a renowned neurologist and Alzheimer’s expert, shares groundbreaking insights into brain health. Representing Axiom Brain Health, Dr. Steen discusses their mission to combat neurodegenerative diseases like Alzheimer’s and Parkinson’s through cutting-edge research and clinical trials. Learn how […]
Health Medicine Network: HMN 2025: How to link blood proteins to Alzheimer’s disease and memory loss
Researchers at Emory Goizueta Brain Health Institute and partner institutions have found new clues in the blood that could help explain why Alzheimer’s disease develops and how it affects memory. The study, published in Nature Aging, examined blood samples from more than 2,100 individuals across four large research cohorts. Using advanced tools, scientists measured thousands of proteins in […]
TrialSite News: GAP Foundation Aims to Improve Speed and Efficiency of Alzheimer’s Trials: An Interview with President John Dwyer
trialsitenews, Aug. 28, 2025, 12:30 p.m. September is Alzheimer’s Awareness Month, a time to reflect on the devastating impact of Alzheimer’s disease and the urgent need for better treatments and care. More than 6 million Americans are living with Alzheimer’s, a number expected to climb steeply in the coming decades. As the need grows, so […]
Accelerating Alzheimer’s Research: Groundbreaking Alzheimer’s Disease Dataset Now Available to the Public
Data from Most Deeply Characterized Cohort Across Alzheimer’s Disease Released byGlobal Alzheimer’s Platform Foundation and Alzheimer’s Disease Data Initiative Washington D.C., July 31, 2025 – The Global Alzheimer’s Platform Foundation® (GAP) and the Alzheimer’s Disease Data Initiative (AD Data Initiative) announced today that data generated from the Bio-Hermes-001 study are now publicly available. This release […]
GAP Experts to Present at Prestigious International Conference
Showcase on Bio-Hermes Data Challenge and Poster Presentation to Take Place at the Alzheimer’s Association International Conference (AAIC) Washington D.C., July 23, 2025- The Global Alzheimer’s Platform Foundation® , (GAP) will have a poster presentation and a Featured Research Session at the 2025 Alzheimer’s Association International Conference (AAIC) being held in Toronto, Canada. Poster Presentation […]
PR Newswire: iLoF and Industry Leader Hamamatsu Announce Strategic Investment in a Collaboration to Advance the Future of Personalized Medicine
iLoF, the leading innovator in AI-powered photonics platforms for personalised medicine, announces today a strategic investment from Hamamatsu, the world expert in the development and manufacturing of photonics devices and systems for medical optics and biophotonics, to further its mission of transforming healthcare and driving innovation in medicine. LONDON, Oct. 22, 2024 /PRNewswire/ — iLoF, the leading company […]
Alzheimer’s Data Challenge Names Winners for Innovative Biomarker Research Competition
Global Researchers Recognized for Trailblazing Projects in First-of-Its-Kind Data Competition Washington D.C., Mar. 27, 2025 – International non-profit organization The Global Alzheimer’s Platform Foundation® (GAP) in collaboration with the Scottish Funding Council’s Brain Health Alliance for Research Challenges (ARC) and the Alzheimer’s Disease Data Initiative proudly announced four winners of the Bio-Hermes Biomarker Data Challenge at the first Data […]
The Pathologist: No Alzheimer’s Patient Left Behind
A blood-based diagnostic test for neurodegenerative diseases is a global priority By Zivjena Vucetic 03/21/2025 As the global population ages, the incidence of neurodegenerative diseases such as Alzheimer’s disease (AD) is rapidly increasing. By 2050, the global population of people over the age of 60 is expected to double, reaching 2.1 billion individuals, while those over 80 […]